HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long elimination half-life of idraparinux may explain major bleeding and recurrent events of patients from the van Gogh trials.

AuthorsJ Harenberg, Y Vukojevic, G Mikus, I Joerg, C Weiss
JournalJournal of thrombosis and haemostasis : JTH (J Thromb Haemost) Vol. 6 Issue 5 Pg. 890-2 (May 2008) ISSN: 1538-7836 [Electronic] England
PMID18315557 (Publication Type: Letter)
Chemical References
  • Oligosaccharides
  • idraparinux
Topics
  • Half-Life
  • Hemorrhage (etiology)
  • Humans
  • Oligosaccharides (pharmacokinetics)
  • Randomized Controlled Trials as Topic
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: